Oxnard et al. [148] demonstrated that the majority of EGFR T790M-related familial LCs are attributed to a relatively recent North American founder mutation, while the worldwide contribution of this allele in LC incidence is very low [148–150]. The gene discussed is EGFR; the disease is laryngotracheoesophageal cleft.